Ticiana De Francesco's profile photo

Ticiana De Francesco

Articles

  • Jun 4, 2024 | dovepress.com | Ticiana De Francesco

    Back to Journals » Clinical Ophthalmology » Volume 18 Authors De Francesco T , Ahmed IIK Received 4 June 2024 Accepted for publication 16 October 2024 Published 19 November 2024 Volume 2024:18 Pages 3335—3341 DOI https://doi.org/10.2147/OPTH.S481318 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 4 Editor who approved publication: Dr Scott Fraser Ticiana De Francesco,1– 3 Iqbal Ike K Ahmed3,4 1Hospital de Olhos Leiria de Andrade, Fortaleza, Brazil;...

  • Dec 28, 2023 | eyetube.net | Ticiana De Francesco

    Advantages of the iTrack Advance Iqbal Ike K. Ahmed, MD, FRCSC; and Ticiana De Francesco, MD Show Description + Iqbal Ike K. Ahmed, MD, FRCSC, speaks with Ticiana De Francesco, MD, about the unique benefits of canaloplasty in the treatment of glaucoma. The two surgeons stress the importance of early intervention to maximize outcomes.

  • Mar 17, 2023 | dovepress.com | Ticiana De Francesco

    Back to Journals » Clinical Ophthalmology » Volume 17 Authors De Francesco T , Ahmed IIK Received 17 March 2023 Accepted for publication 1 June 2023 Published 21 August 2023 Volume 2023:17 Pages 2483—2492 DOI https://doi.org/10.2147/OPTH.S409958 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Scott Fraser Ticiana De Francesco,1– 3 Iqbal Ike K Ahmed3,4 1Clinica de Olhos De Francesco, Fortaleza, Brazil; 2Hospital de...

  • Feb 28, 2023 | ajo.com | Arsham Sheybani |Ticiana De Francesco |Jonathan H. Lass |Beth Ann Benetz

    AbstractPurposeTo report 5-year postoperative safety data of iStent inject, including overall stability, endothelial cell density (ECD), and endothelial cell loss (ECL) in patients with mild-to-moderate primary open-angle glaucoma (POAG).

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →